Peer-Review Record
The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma
Cancers 2022, 14(13), 3125; https://doi.org/10.3390/cancers14133125
by
Luo Chen 1,†, Yiu Chun Chiang 1,†, Lai Sheung Chan 2, Wai Yin Chau 2, Maria Li Lung 3
, Michael Kahn 4, Kwok Wai Lo 5,6, Nai Ki Mak 1 and Hong Lok Lung 2,*
, Michael Kahn 4, Kwok Wai Lo 5,6, Nai Ki Mak 1 and Hong Lok Lung 2,*
Cancers 2022, 14(13), 3125; https://doi.org/10.3390/cancers14133125
Submission received: 13 June 2022
/
Accepted: 17 June 2022
/
Published: 25 June 2022
(This article belongs to the Special Issue A Deeper Dive into Signaling Pathways in Cancers)
Round 1
Reviewer 1 Report
The manuscript titled: “The CBP/β-catenin antagonist, ICG-001, inhibits tumor metastasis via blocking of the miR-134/ITGB1 axis-mediated cell adhesion in nasopharyngeal carcinoma” is well written with a unique scientific concept in the current cancer biology field. I have no comments on the current manuscript. I would suggest accepting the manuscript in its present form.
Reviewer 2 Report
Thanks for addressing the comments.
Reviewer 3 Report
The authors have satisfactorily addressed all the concerns raised in the previous round.
